IL15 and infection: Because IL-15−/− mice exhibit a severe developmental defect in both NK and NKT cell lineages and are nearly devoid of these cell populations [20], we chose to use an anti-IL-15 blocking antibody to selectively deplete IL-15 concurrent with infection.